A rapid, efficient, and cost-effective method for titering third-generation lentiviral vectors
Innovative Medicines & Omics · 2025
DOI: 10.36922/imo.6552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovative Medicines & Omics, 2025. Verfasst von Binhai Ren und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Lentiviral vectors are useful vectors for stable transduction and permanent expression in dividing and non-dividing cells. In particular, third-generation lentiviral vectors have been engineered to be significantly safer than their second-generation counterparts, incorporating several safety features not present in earlier versions. For example, the tat gene, which is essential for the replication of wild-type human immunodeficiency virus type 1, has been deleted, and vector packaging functions have been distributed across three separate plasmids, further enhancing safety. In both research and clinical settings, having a reliable and accurate method for titering lentiviral vectors is critical. We have developed a method using the Woodchuck Hepatitis Virus Post-transcriptional Regulatory Element as a template for a real-time quantitative polymerase chain reaction, coupled with TRIzol lysis buffer for ribonucleic acid isolation. This method yielded results comparable to those from a commonly used commercial kit, offering advantages of speed, cost-effectiveness, and accuracy. It presents a viable, economical alternative for both research and clinical laboratories.
Zitieren
APA
Ren, B., Nassif, N. T., & Simpson, A. M. (2025). A rapid, efficient, and cost-effective method for titering third-generation lentiviral vectors. Innovative Medicines & Omics. https://doi.org/10.36922/imo.6552
Vancouver
Ren B, Nassif NT, Simpson AM. A rapid, efficient, and cost-effective method for titering third-generation lentiviral vectors. Innovative Medicines & Omics. 2025. doi:10.36922/imo.6552
BibTeX
@article{Ren2025,
author = {Ren, Binhai and Nassif, Najah T. and Simpson, Ann M.},
title = {A rapid, efficient, and cost-effective method for titering third-generation lentiviral vectors},
journal = {Innovative Medicines & Omics},
year = {2025},
doi = {10.36922/imo.6552}
}
EUVIMED